Cargando…

Personality Disorders among Patients with Mental and Behavioral Disorders due to Psychoactive Substance Use in a Tertiary Care Center of Nepal: A Descriptive Cross-sectional Study

INTRODUCTION: Personality disorders is comprised of deeply ingrained and enduring behavioral patterns, manifesting themselves as inflexible responses to a broad range of personal and social situations.” Personality Disorders are frequently occurring among patients with substance use disorders. Co-oc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rawal, Namrata Mahara, Pradhan, Monalisha, Adhikari, Suman Prasad, Manandhar, Pradeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of the Nepal Medical Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959231/ https://www.ncbi.nlm.nih.gov/pubmed/34506452 http://dx.doi.org/10.31729/jnma.6176

Ejemplares similares

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
por: Dal Farra, Deborah, et al.
Publicado: (2022)

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
por: Alías-Ferri, Maria, et al.
Publicado: (2022)

Study on prevalence of suicidal ideation and risk factors of suicide among patients visiting psychiatric OPD at Shree Birendra Hospital, Kathmandu Nepal
por: Katuwal, Nagendra, et al.
Publicado: (2021)

Toxoplasma gondii exposure in patients suffering from mental and behavioral disorders due to psychoactive substance use
por: Alvarado-Esquivel, Cosme, et al.
Publicado: (2015)

Disorders Related to Use of Psychoactive Substances in DSM-5: Changes and Challenges
por: Bhad, Roshan, et al.
Publicado: (2015)

Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey
por: Shrestha, Dhan, et al.
Publicado: (2021)

Prevalence of Psychoactive Drug Use among Medical Students in a Medical College of Nepal
por: Shrestha, Jyoti Tara Manandhar, et al.
Publicado: (2020)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

The influence of tightening regulations on patients with new psychoactive substance‐related disorders in Japan
por: Tanibuchi, Yuko, et al.
Publicado: (2018)

Emotional disorder dynamics for patients depending on psychoactive substances at the stages of psychosocial rehabilitation
por: Mykhaylov, B., et al.
Publicado: (2021)

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
por: Więckiewicz, Gniewko, et al.
Publicado: (2023)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Bergenia pacumbis from Nepal, an astonishing enzymes inhibitor
por: Pandey, Bishnu Prasad, et al.
Publicado: (2020)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

Anxiety among Pregnant Women about Corona Virus Infections during COVID-19 Pandemic at a Tertiary Care Center in Nepal: A Descriptive Cross-sectional Study
por: Shrestha, Dipty, et al.
Publicado: (2021)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Tuberculosis among Patients Admitted to the Department of Medicine of a Tertiary Care Center in Nepal: A Descriptive Cross-sectional Study
por: Thapa, Suman, et al.
Publicado: (2021)

Prevalence of Dangerous Ethmoid in a Tertiary Center in Eastern Nepal
por: Mishra, Sudeep, et al.
Publicado: (2019)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Culture Positive Cases of Ophthalmia Neonatorum in a Tertiary Care Centre of Nepal: A Descriptive Cross-sectional Study
por: Shrestha, Sabina, et al.
Publicado: (2021)

A Peer Support Scale for Adults Treated for Psychoactive Substance–Use Disorder: A Rasch Analysis
por: Mazurek, Kathryn D, et al.
Publicado: (2015)

Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
por: Zongo, Arsène, et al.
Publicado: (2021)

Does antipsychotic therapy prevent the development of chronic psychotic disorders in people addicted to ilegal psychoactive substances
por: Kasper, S. S., et al.
Publicado: (2023)

A qualitative study to understand drivers of psychoactive substance use among Nepalese youth
por: Bhandari, Tulsi Ram, et al.
Publicado: (2021)

Psychoactive substances and the political ecology of mental distress
por: Aggarwal, Sunil K, et al.
Publicado: (2012)

PSYCHOACTIVE SUBSTANCE USE AMONG MEDICAL STUDENTS
por: Ali, R.V. Zulfikar, et al.
Publicado: (1994)

Banning Psychoactive Substances: A Slippery Slope
Publicado: (2015)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Experimentation with psychoactive substances by public school students
por: de Andrade, Maria Eliane, et al.
Publicado: (2017)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

New psychoactive substances: a review and updates
por: Shafi, Abu, et al.
Publicado: (2020)

Psychoactive Substances Taken with Mephedrone and HCV Infection
por: Ordak, Michal, et al.
Publicado: (2021)

Molecular Insights on New Psychoactive Substances (NPSs)
por: Busardò, Francesco Paolo, et al.
Publicado: (2022)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
por: Chiappini, Stefania, et al.
Publicado: (2023)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
por: Deen, Adrian A, et al.
Publicado: (2021)

Anxiety and Depression among Hypertensive Adults in Tertiary Care Hospitals of Nepal
por: Shah, Sangam, et al.
Publicado: (2022)

Hospitalization due to mental and behavioral disorders caused by use of alcohol and psychoactive substances among older adults and elderly people in Brazil: a cross-sectional study
por: Afonso, Pedro Paulo Luciano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fd7jue2417bonhg5c2o029thc